Bristol-Myers Squibb

Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Pfizer
immuno-oncology
AstraZeneca
Bristol-Myers Squibb
Merck
Roche
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Motley Fool
Mon, 02/16/15 - 10:19 am
Pfizer
Hospira
M&A
Teva Pharmaceutical
AbbVie
Bristol-Myers Squibb
Abbott Labs
Mylan
GSK
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Pfizer Inc. Is Not Done With Acquisition Deals Yet
Bidness Etc.
Mon, 02/9/15 - 10:02 am
Pfizer
M&A
Hospira
Actavis
GSK
Bristol-Myers Squibb
Moody's: Patent-cliff challenges will continue to dog big pharma
BioPharma Dive
Wed, 02/4/15 - 01:43 pm
patents
patent cliff
Big Pharma
Pfizer
Eli Lilly
Merck
Amgen
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
Bristol-Myers Squibb: Q4 2014 Earnings Review And The Way Forward
Seeking Alpha
Mon, 02/2/15 - 08:32 am
earnings
Bristol-Myers Squibb
FDA approves Bristol-Myers' HIV drug
Yahoo/Reuters
Thu, 01/29/15 - 07:20 pm
FDA
Bristol-Myers Squibb
HIV
Reyataz
Novartis, Pfizer and Bristol-Myers hit the gas on R&D last year
Fierce Biotech
Wed, 01/28/15 - 08:29 am
Novartis
Pfizer
Bristol-Myers Squibb
R&D
Bristol, Pfizer, Novartis Forecasts Face FX Pressures
Investors.com
Tue, 01/27/15 - 04:31 pm
Novartis
Pfizer
Bristol-Myers Squibb
earnings
foreign exchange rates
Bristol-Myers beats Street 4Q forecasts
Yahoo/AP
Tue, 01/27/15 - 08:25 am
Bristol-Myers Squibb
earnings
What to Expect When Bristol-Myers Squibb (BMY) Reports Fourth-Quarter Earnings Tomorrow
TheStreet.com
Mon, 01/26/15 - 06:44 pm
earnings
Bristol-Myers Squibb
Bristol-Myers Squibb CEO steps down, replaced by COO
Fortune
Tue, 01/20/15 - 11:02 pm
Bristol-Myers Squibb
Lamberto Andreotti
Pharma CEOs
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Lilly to Pair With Merck, Bristol on Cancer Drug Trials
WSJ Online
Tue, 01/13/15 - 09:54 am
Eli Lilly
Merck
Bristol-Myers Squibb
immunotherapy
clinical trials
Merck and Bristol-Myers Rivalry in Cancer Drugs Heats Up, Again
WSJ Pharmalot
Mon, 01/12/15 - 12:52 pm
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Neutral Forecast For Bristol-Myers Squibb
Seeking Alpha
Mon, 01/12/15 - 09:50 am
Bristol-Myers Squibb
Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival
TheStreet.com
Mon, 01/12/15 - 08:02 am
Bristol-Myers Squibb
Opdivo
lung cancer
squamous cell non-small cell lung cancer
Next-Generation Diabetes Drug Offers Great Growth Potential
Motley Fool
Sat, 01/10/15 - 01:11 pm
diabetes
Novo Nordisk
Perle Biosciences
PRL001
PRL002
JNJ
AstraZeneca
Bristol-Myers Squibb
Bristol-Myers Squibb Has A Real Shot At A Home Run In Hepatitis C
Seeking Alpha
Thu, 01/8/15 - 08:21 am
Bristol-Myers Squibb
hepatitis C
Daklinza
Sunvepra
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:24 pm
Actavis
Celgene
Amgen
AbbVie
Gilead Sciences
Eli Lilly
Novartis
AstraZeneca
Merck
JNJ
Biogen Idec
Novo Nordisk
Roche
Bristol-Myers Squibb
Pfizer
GSK
Sanofi

Pages